| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | T41737F88A |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| BINDING AGENT | Coagulation factor III binding agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Uterine Cervical Neoplasms | 4 | D002583 | ClinicalTrials | ||
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials | ||
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials | ||
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials | ||
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297841 |
| FDA SRS | T41737F88A |
CONTENTS